亡:一种独特的细胞死亡模式,用于向癌症
Sweata Hanson1, Aiswarya Dharan1, Jinsha P V1
1School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam, Kerala, India.
Frontiers in pharmacology
|July 3, 2023
概括
帕拉普托斯是一种替代的编程细胞死亡 (PCD) 途径,通过克服化疗耐药性,提供了一种新的抗癌策略. 了解帕帕托斯调节器是开发新癌症疗法的关键.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 编程细胞死亡 (PCD) 对平衡,发育和疾病至关重要,而亡是主要形式.
- 癌细胞经常逃避细胞亡,导致治疗耐药性,并需要替代细胞死亡策略.
- 被真空化和器官损伤所特征的帕拉普,呈现出一种独特的PCD途径,在癌症治疗中具有潜力.
研究的目的:
- 审查调节器和触发亡的机制.
- 探索帕帕托斯在癌症免疫和治疗中的作用.
- 讨论癌症的亡研究当前的挑战和未来方向.
主要方法:
- 文献综述侧重于帕帕托斯诱导和机制.
- 在各种癌症模型 (细胞系,异种移植,斑马鱼) 中分析研究的分析.
- 检查帕帕托斯在组合疗法和预后模型中的作用.
主要成果:
- 亡可以由自然化合物和金属复合物诱导,为亡提供了一个替代方案.
- 新出现的证据强调了帕帕托斯在产生抗瘤T细胞免疫和其他免疫反应中的作用.
- 用各种模型进行的研究表明,帕帕托斯在癌症治疗中的潜力及其与患者结果的关联.
结论:
- 帕拉普托斯是一种有希望的PCD替代途径,可以克服癌症的化疗耐药性.
- 对亡机制和调节器的进一步研究对于开发新型癌症疗法至关重要.
- 基于帕拉普托斯的策略具有显著的潜力,可以提高癌症治疗效率和患者预后.
更多相关视频
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.2K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
Overview of Cell Death
7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Apoptosis
11.6K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.6K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Phagocytosis of Apoptotic Cells
3.9K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
